Researchers from the Cleveland Clinic have developed what could become a new class of cardiovascular drugs—one that lowers platelet responsiveness and excessive clot formation by targeting a specific bacteria byproduct in the gut.

A 13-gene signature can separate Kawasaki disease from other febrile and inflammatory conditions, potentially opening the door to blood tests that allow quicker treatment and the prevention of coronary artery aneurysms.

Atrial fibrillation (AFib) and atrial flutter (AFL) are often regarded as interchangeable when informing the management of stroke risk. However, a new study in JAMA Network Open suggests clinical outcomes are worse for patients with AFib, even if they have the same values on the standard CHA2DS2-VASc scoring system.

Smoking hookah for 30 minutes causes changes in arterial stiffness similar to what’s seen after someone smokes a cigarette, according to a study published in the American Journal of Cardiology.

Researchers with LSU Health New Orleans School of Medicine believe they’ve discovered a molecular explanation for why hypoxia increases the risk for blood clots.

Rapid Medical has received CE mark approval for its Tigertriever 13 clot retriever, the smallest such device on the market which is designed to treat intracranial vessels between one and 2.5 millimeters.

Having a multidisciplinary team available around-the-clock to meet patients with suspected emergent large vessel occlusion (ELVO) strokes helped a hospital achieve median door-to-recanalization times of 52 minutes, according to a study presented at the Society of NeuroInterventional Surgery’s annual meeting.

Contrary to popular belief, full-fat dairy products are not directly associated with increasing cardiovascular disease (CVD) and stroke mortality, according to a new study published in the American Journal of Clinical Nutrition.